High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

被引：0

作者：

De Caterina, R. ^{[1
]}

Lopez Sendon, J. L. ^{[2
]}

Mehta, S. ^{[3
]}

Opolski, G. ^{[4
]}

Oldgren, J. ^{[5
]}

Steg, P. G. ^{[6
]}

Hohnloser, S. ^{[7
]}

Lip, G. Y. H. ^{[8
]}

Kimura, T. ^{[9
]}

Nordaby, M. ^{[10
]}

Kleine, E. ^{[10
]}

Ten Berg, J. M. ^{[11
]}

Bhatt, D. L. ^{[12
]}

Cannon, C. ^{[13
]}

机构：

[1] Univ G dAnnunzio, Chieti, Italy

[2] Univ Hosp La Paz, Madrid, Spain

[3] McMaster Univ, Hamilton, ON, Canada

[4] Med Univ Warsaw, Warsaw, Poland

[5] Uppsala Univ, Uppsala, Sweden

[6] Hosp Bichat Claude Bernard, Paris, France

[7] Goethe Univ Frankfurt, Frankfurt, Germany

[8] Birmingham City Hosp, Birmingham, W Midlands, England

[9] Kyoto Univ, Kyoto, Japan

[10] Boehringer Ingelheim Int GmbH, Ingelheim, Germany

[11] St Antonius Hosp, Nieuwegein, Netherlands

[12] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[13] Baim Inst Clin Res, Boston, MA USA

来源：

EUROPEAN HEART JOURNAL | 2018年 / 39卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P2298

引用

页码：458 / 458

页数：1

共 50 条

[1] Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI
De Caterina, Raffaele
Procopio, Antonio
Lopez Sendon, Jose-Luis
Raev, Dimitar
Mehta, Shamir R.
Opolski, Grzegorz
Oldgren, Jonas
Steg, Philippe Gabriel
Hohnloser, Stefan H.
Lip, Gregory Y. H.
Kimura, Takeshi
Kleine, Eva
ten Berg, Jurrien M.
Bhatt, Deepak L.
Miede, Corinna
Nordaby, Matias
Cannon, Christopher P.
AMERICAN JOURNAL OF MEDICINE, 2020, 133 (11): : 1302 - 1312
[2] Subgroup Analysis From the RE-DUAL PCI Trial: Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Oldgren, Jonas
Steg, Philippe-Gabriel
Hohnloser, Stefan H.
Lip, Gregory Y.
Ellis, Stephen G.
Kimura, Takeshi
Nordaby, Matias
ten Berg, Jurrien M.
Bhatt, Deepak L.
Cannon, Christopher P.
Kleine, Eva
CIRCULATION, 2017, 136 (24) : E457 - E457
[3] DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI
Hohnloser, Stefan
Steg, Philippe
Oldgren, Jonas
Nickenig, Georg
Kiss, Robert Gabor
Ongen, Zeki
Estrada, Jose Navarro
Ophuis, Ton Oude
Lip, Gregory
Nordaby, Matias
Kleine, Eva
Ten Berg, Jurrien
Bhatt, Deepak
Cannon, Christopher
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 314 - 314
[4] Dual antithrombotic therapy with dabigatran vs triple therapy with warfarin after PCI in patients with atrial fibrillation and diabetes mellitus (a RE-DUAL PCI subgroup analysis)
Maeng, M.
Steg, P. G.
Bhatt, D. L.
Hohnloser, S. H.
Nordaby, M.
Miede, C.
Kimura, T.
Lip, G. Y. H.
Oldgren, J.
Ten Berg, J. M.
Cannon, C. P.
EUROPEAN HEART JOURNAL, 2018, 39 : 1090 - 1091
[5] DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN VERSUS TRIPLE THERAPY WITH WARFARIN AFTER PCI IN PATIENTS WITH ATRIAL FIBRILLATION AND DIABETES MELLITUS (A RE-DUAL PCI™ SUBGROUP ANALYSIS)
Ruggieri, G.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E114 - E115
[6] Benefit of Dual versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Stenting: Insights From a Landmark Analysis of RE-DUAL PCI
Peterson, Benjamin E.
Bhatt, Deepak L.
Steg, Philippe Gabriel
Oldgren, Jonas
Maeng, Michael
Zeymer, Uwe
Halvorsen, Sigrun
Hohnloser, Stefan H.
Lip, Gregory Y.
Kimura, Takeshi
Nordaby, Matias
Kleine, Eva
ten Berg, Jurrien M.
Cannon, Christopher
CIRCULATION, 2018, 138
[7] The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial
Ten Berg, J. M.
Steg, P. G.
Bhatt, D. L.
Hohnloser, S. H.
De Veer, A. N. N. E.
Nordaby, M.
Miede, C.
Kimura, T.
Lip, G. Y. H.
Oldgren, J.
Cannon, C. P.
EUROPEAN HEART JOURNAL, 2018, 39 : 439 - 440
[8] The effect of sex on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial
Eccleston, D.
Ten Berg, J. M.
Steg, P. G.
Bhatt, D. L.
Hohnloser, S. H.
De Veer, A.
Nordaby, M.
Miede, C.
Kimura, T.
Lip, G. Y. H.
Oldgren, J.
Cannon, C. P.
EUROPEAN HEART JOURNAL, 2020, 41 : 33 - 34
[9] Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
Hohnloser, Stefan H.
Steg, Philippe Gabriel
Oldgren, Jonas
Nickenig, Georg
Kiss, Robert G.
Ongen, Zeki
Navarro Estrada, Jose L.
Ophuis, Ton Oude
Lip, Gregory Y. H.
Nordaby, Matias
Kleine, Eva
ten Berg, Jurrien M.
Bhatt, Deepak L.
Cannon, Christopher P.
JACC-CARDIOVASCULAR INTERVENTIONS, 2019, 12 (16) : 1553 - 1561
[10] The effect of sex on the efficacy and safety of dual antithrombotic therapy with dabigatran versus triple therapy with warfarin after PCI in patients with atrial fibrillation (a RE-DUAL PCI subgroup analysis and comparison to other dual antithrombotic therapy trials)
Eccleston, David S.
Kim, Joseph M.
ten Berg, Jurien M.
Steg, P. Gabriel
Bhatt, Deepak L.
Hohnloser, Stefan H.
de Veer, Anne
Nordaby, Matias
Miede, Corinna
Kimura, Takeshi
Lip, Gregory Y. H.
Oldgren, Jonas
Cannon, Christopher P.
CLINICAL CARDIOLOGY, 2021, 44 (07) : 1002 - 1010

← 1 2 3 4 5 →